Trials / Completed
CompletedNCT00954018
Microbial Community Composition and Metabolism in Cystic Fibrosis
Respiratory Microbial Community Composition and Metabolism in Cystic Fibrosis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- Boston Children's Hospital · Academic / Other
- Sex
- All
- Age
- 2 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Scientist have begun to realize that many types of bacteria often live together as a complex community, and the investigators wish to apply that idea to the bacteria in the respiratory system of people with Cystic Fibrosis (CF). It is possible that the survival of the many millions of bacteria in the CF lung depends on the production of special chemicals that might be made only by very few types of bacteria. If that is true, medicines that interfere with those chemicals could treat the lung infections that cause trouble for nearly all people with CF. The investigators wish to study the production of several potentially critical chemicals by the respiratory bacteria and to examine the effect of those chemicals on the makeup of the entire community of bacteria. To detect all the bacteria in that community, the investigators will use new methods that use bacterial genetic information and can detect hundreds of different types of bacteria in respiratory samples of individual CF patients.
Conditions
Timeline
- Start date
- 2009-08-01
- Primary completion
- 2017-11-10
- Completion
- 2017-11-10
- First posted
- 2009-08-06
- Last updated
- 2023-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00954018. Inclusion in this directory is not an endorsement.